Diligent Robotics is a technology company.
Diligent Robotics has raised $79.0M across 5 funding rounds.
Diligent Robotics has raised $79.0M in total across 5 funding rounds.
Diligent Robotics has raised $79.0M in total across 5 funding rounds.
Diligent Robotics's investors include Alumni Ventures, Austin Ventures, Canaan Partners, Capital Factory, DNX Ventures, Energy Impact Partners, Inspired Capital, Johnson, Jump Capital, LiveOak Venture Partners, Next Coast Ventures, OODA Ventures.
Diligent Robotics is a private AI and robotics company founded in 2017 and headquartered in Austin, Texas, specializing in human-centered robots that assist healthcare workers with routine, non-patient-facing tasks.[1][2][3] Their flagship product, Moxi, is a socially intelligent mobile manipulator robot that fetches medications, lab samples, supplies, and performs deliveries in hospitals, freeing up staff time for patient care, improving outcomes, and addressing shortages.[2][3][5] With over 207 employees and deployments in more than 25 U.S. hospitals, including major systems like Cedars Sinai and Northwestern Medicine, the company has raised nearly $50 million in funding, including a $30 million Series B in 2022, and operates one of the largest NVIDIA-powered robot fleets in healthcare.[1][4][5][7] Moxi integrates with hospital systems like electronic health records, supports 24/7 operations, and delights patients with friendly interactions like waving.[3]
Diligent Robotics was co-founded in 2017 by Andrea Thomaz, PhD (CEO) and Vivian Chu, PhD (CTO), both women roboticists trained at MIT and Georgia Tech, with additional research shaping from the University of Texas at Austin.[2][3][7] The idea emerged from their expertise in social robotics, focusing on robots that collaborate seamlessly with humans in dynamic environments like hospitals, emphasizing mobile manipulation, social intelligence, and human-guided learning.[1][2][3] Early traction began in 2018 with Moxi's debut and research trials partnering with four Texas health systems, incorporating clinician feedback to refine workflows; commercial deployments started in 2020, proving value in clinical flows amid nursing shortages.[4]
Diligent Robotics rides the healthcare robotics and AI automation trend, targeting persistent nursing shortages, stalled productivity, and high turnover exacerbated by logistical burdens on staff.[3][4][7] Timing aligns with post-pandemic labor crises and AI advancements in mobile manipulators, enabling scalable deployments in "controlled chaos" environments where humanoid-like collaboration is key.[1][5][7] Market forces like rising hospital costs and demand for patient-focused care favor them, as Moxi creates revenue opportunities (e.g., Meds-to-Beds) while integrating with existing infrastructure.[3][4] They influence the ecosystem by pioneering social robotics in clinical settings, paving the way for broader adoption in healthcare and expansions like senior living via AARP programs.[5]
Diligent is poised to scale Moxi 2.0 deployments starting 2026, doubling hospital sites annually en route to thousands of units by 2030, with enhanced AI driving larger fleets and new sectors like senior care.[5] Trends in NVIDIA-powered edge AI, humanoid robotics maturation, and healthcare automation will accelerate growth, potentially tripling usage as staffing pressures intensify.[5][7] Their influence may evolve from niche hospital assistant to standard infrastructure, redefining human-robot teams and boosting investor returns in a ripe disruption market—building on their human-centric foundation to transform care delivery.[1][3][7]
Diligent Robotics has raised $79.0M across 5 funding rounds. Most recently, it raised $34.0M Venture Round in September 2023.